Megaly, Michael
Buda, Kevin G.
Xenogiannis, Iosif
Vemmou, Evangelia
Nikolakopoulos, Ilias
Saad, Marwan
Rinfret, Stéphane
Abbott, J. Dawn
Aronow, Herbert D.
Garcia, Santiago
Pershad, Ashish
Burke, M. Nicholas
Brilakis, Emmanouil S.
Article History
Received: 29 July 2020
Accepted: 21 September 2020
First Online: 10 October 2020
Compliance with ethical standards
:
: Emmanouil Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Ebix, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; research support from Regeneron and Siemens. Shareholder: MHI Ventures. M. Nicholas Burke: Shareholder, Egg Medical and MHI Ventures. Speaker, Opsens Medical. Santiago Garcia: Consultant for Surmodics, Osprey Medical, Medtronic, Edwards Lifesciences, and Abbott Vascular. Dr. Institutional grant support from Edwards Lifesciences, Abbott Vascular, and BSCI. Honoraria from the American College of Cardiology. Stephane Rinfret: Consultant, Boston Scientific, Abiomed, Abbott Vascular and Soundbite Medical. J Dawn Abbott: Research consultant for Pfizer and Recork. Herbert Aronow: Consultant, Silk Road Medical, Philips. All other authors have nothing to disclose.